Gross domestic expenditure on R&D by sector of performance and source of funds — Gross Domestic Expenditure on R&D (GERD) by country

This table contains gross research and development (R&D) expenditure statistics broken down by sector of performance (business enterprise, government, higher education, private non-profit, and total intramural) and by source of funds (business enterprise, government - including public general university funds -,...

Countries reporting
44
Highest
204,376 US dollars, PPP converted
Japan
Lowest
393.92 US dollars, PPP converted
Costa Rica
Median
9,605 US dollars, PPP converted
Years covered
45
1981–2025
Data points
1,579

What the numbers show

Gross domestic expenditure on R&D by sector of performance and source of funds — Gross Domestic Expenditure on R&D (GERD) is currently reported for 44 countries. The highest value is 204,376 US dollars, PPP converted in Japan; the lowest is 393.92 US dollars, PPP converted in Costa Rica.

The median across all reporting countries is 9,605 US dollars, PPP converted, and the mean is 45,242 US dollars, PPP converted.

The gap between the highest and lowest reporting country is a factor of about 519.

Over the past decade 40 countries rose and 4 fell. The largest increase was in Türkiye (up 175.8%), and the largest decrease in Costa Rica (down 28.0%).

Gross domestic expenditure on R&D by sector of performance and source: full country ranking

#Country LatestYear 10-year changeTrend
1 Japan 204,376 US dollars, PPP converted 2024 up 13.2% rising
2 United States 847,935 US dollars, PPP converted 2024 up 62.7% rising
2 Germany 159,537 US dollars, PPP converted 2024 up 21.1% rising
3 France 82,108 US dollars, PPP converted 2024 up 7.9% rising
4 United Kingdom 102,458 US dollars, PPP converted 2023 up 100.4% rising
4 Taiwan, China 65,085 US dollars, PPP converted 2024 up 88.4% volatile
5 Russian Federation 47,954 US dollars, PPP converted 2020 up 18.4% rising
5 Türkiye 45,563 US dollars, PPP converted 2024 up 175.8% volatile
6 Italy 42,368 US dollars, PPP converted 2024 up 15.4% rising
6 Netherlands 28,006 US dollars, PPP converted 2024 up 28.9% rising
7 Canada 40,121 US dollars, PPP converted 2025 up 32.3% rising
7 Poland 22,791 US dollars, PPP converted 2024 up 113.4% volatile
8 Spain 33,629 US dollars, PPP converted 2024 up 49.9% volatile
8 Slovenia 2,202 US dollars, PPP converted 2024 up 20.7% rising
9 Israel 30,586 US dollars, PPP converted 2024 up 126.3% volatile
10 Australia 26,905 US dollars, PPP converted 2023 up 1.6% volatile
10 Croatia 2,048 US dollars, PPP converted 2024 up 143.7% rising
11 Belgium 24,739 US dollars, PPP converted 2024 up 67.7% rising
11 Lithuania 1,371 US dollars, PPP converted 2024 up 38.6% volatile
12 Sweden 22,720 US dollars, PPP converted 2024 up 36.1% rising
12 Estonia 1,115 US dollars, PPP converted 2024 up 69.7% rising
13 Switzerland 22,104 US dollars, PPP converted 2023 up 36.1% rising
13 Latvia 615.53 US dollars, PPP converted 2024 up 54.5% rising
14 Austria 18,558 US dollars, PPP converted 2024 up 18.1% volatile
15 Singapore 13,603 US dollars, PPP converted 2023 up 43.5% rising
16 Denmark 12,265 US dollars, PPP converted 2024 up 27.0% rising
17 Finland 9,734 US dollars, PPP converted 2024 up 11.2% rising
18 Czechia 9,476 US dollars, PPP converted 2024 up 16.1% rising
19 Ireland 8,479 US dollars, PPP converted 2024 up 95.9% volatile
20 Mexico 8,424 US dollars, PPP converted 2017 down 1.7% rising
21 Norway 8,288 US dollars, PPP converted 2024 up 26.7% rising
22 Portugal 7,636 US dollars, PPP converted 2024 up 66.3% volatile
23 Argentina 6,914 US dollars, PPP converted 2023 down 4.9% rising
24 Greece 5,832 US dollars, PPP converted 2024 up 109.4% volatile
25 South Africa 5,107 US dollars, PPP converted 2023 up 0.3% rising
26 Hungary 5,032 US dollars, PPP converted 2024 up 27.7% rising
27 New Zealand 3,937 US dollars, PPP converted 2023 up 84.5% volatile
28 Romania 3,236 US dollars, PPP converted 2024 up 65.5% rising
29 Colombia 2,274 US dollars, PPP converted 2020 up 91.0% rising
30 Chile 2,189 US dollars, PPP converted 2022 up 34.0% rising
31 Bulgaria 1,530 US dollars, PPP converted 2024 up 29.2% rising
32 Luxembourg 811.42 US dollars, PPP converted 2024 down 2.1% flat
33 Iceland 610.82 US dollars, PPP converted 2024 up 72.5% volatile
34 Costa Rica 393.92 US dollars, PPP converted 2024 down 28.0% falling

Regions and income groups

Aggregates are excluded from the country ranking above so that a region can never outrank a country.

Share, cite or embed this page

Cite this page

Gross domestic expenditure on R&D by sector of performance and source by country. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 08 September 2026, from https://reference.statizoid.com/stat/gross-domestic-expenditure-on-r-and-d-by-sector-of-performance-and-source-of-funds-gross/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gross-domestic-expenditure-on-r-and-d-by-sector-of-performance-and-source-of-funds-gross/">Gross domestic expenditure on R&D by sector of performance and source by country</a> — Statizoid

About this data

Indicator
Gross domestic expenditure on R&D by sector of performance and source of funds — Gross Domestic Expenditure on R&D (GERD)
Unit
US dollars, PPP converted
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
47 places, 1,579 data points, 1981–2025
Last refreshed

This table contains gross research and development (R&D) expenditure statistics broken down by sector of performance (business enterprise, government, higher education, private non-profit, and total intramural) and by source of funds (business enterprise, government - including public general university funds -, higher education, private non-profit and funds from the rest of the World - including funds from enterprises and other funds from the rest of the World).